Hancock Whitney HWC Q3 2024 Earnings Transcript

Hancock Whitney reported Q3 net income of $116 million, or $1.33 per share, with ROA at 1.32% and PPNR up 10% to $167 million as NIM expanded 2 bps to 3.39%. Fee income rose 8% and expenses fell 1%, while the bank continued to reduce SNC exposure, repurchased over 300,000 shares, and ended with strong capital ratios (TCE 9.56%, CET1 13.79%). Management raised 2024 non-interest income guidance to 6%-7% growth and expects modest further NIM expansion, though loan growth remains constrained until balance sheet expansion resumes.

Analysis

HWC’s quarter is less about the headline earnings beat and more about the shape of the earnings base. The bank is converting a one-time de-risking program into a cleaner growth runway: once the SNC runoff stops acting as a drag, incremental loan growth and banker hiring should show up directly in revenue rather than just offsetting balance-sheet shrinkage. That matters because the next leg of upside is no longer balance-sheet repair; it’s operating leverage from adding assets on top of a still-healthy deposit franchise.

The margin setup looks better than the market may be pricing, but the real kicker is timing mismatch. Deposit repricing should move quickly over the next 1-2 quarters, while loan yield pressure from rate cuts and slower commercial demand will lag; simultaneously, the bond book is rolling into meaningfully higher reinvestment yields. That combination can keep NIM drifting up even if loan growth is only modest, which creates a window where consensus may be too focused on the loan-growth optics and not enough on asset/liability repricing math.

Credit is the main source of debate, but the important read-through is that criticized migration appears more like portfolio cleansing plus late-cycle monitoring than broad deterioration. The risk is not a sudden charge-off spike; it’s that lower rates do not immediately solve demand softness for C&I borrowers, so migration can stay elevated for several quarters even as actual losses remain contained. That creates a classic lagging-negative / leading-positive setup: the stock can rerate before credit fully clears, but any macro slowdown or delayed election-related CapEx could keep the multiple capped until 2025 guidance proves organic growth can absorb the cleanup.

Contrarian view: the market may be underestimating how much capital flexibility HWC now has. With top-quartile capital and buybacks still active, management can support EPS even if near-term loan growth is choppy, and then re-accelerate repurchases if hiring doesn’t translate quickly. The better trade is not on peak earnings; it’s on the probability that 2025 becomes the first year in a while where growth, margin expansion, and capital return all work in the same direction.

Key Decisions for Investors

• Long HWC for 3-6 months into 2025 guidance: buy on any post-earnings weakness and target a rerating as SNC drag rolls off and deposit/bond repricing supports NIM; downside is limited by capital return, upside is a cleaner growth narrative.
• Pair trade: long HWC / short a regional bank with weaker deposit mix or heavier CRE exposure over 1-2 quarters; HWC has better self-help via repricing and buybacks while credit optics are improving faster than peers.
• Use HWC Jan-2025 or Apr-2025 call spreads to express a modest bullish view with defined risk; the catalyst stack is Q4 margin expansion plus January hiring/growth commentary, while the main risk is slower loan demand.
• If HWC rallies sharply before 2025 guidance, trim 30-40% of exposure; the market may overpay for the NIM story before organic loan growth is validated.
• Avoid shorting HWC on the criticized-loan headline alone; any short thesis needs a macro credit deterioration catalyst, not just migration from the SNC review.